INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
CL
Cunningham LyleChief Banking Officer
CUBICustomers Bancorp, Inc.
Tax withholding
F$57K
749 sh
Jan 5, 2026Jan 7, 2026
Page 1525 of 1814
← PrevNext →
traded Jan 5, 2026
+2d
SEC Form 4

Evidence

12
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

12
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

12
ER
Enslin RobertPresident, CCO
WDAYWorkday, Inc.
Tax withholding · 10b5-1 plan
F$2.73M
13.3K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

12
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

11
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Grant or award
A$9,625
34 sh
Dec 31, 2025Jan 7, 2026
traded Dec 31, 2025
+7dSEC Form 4

Evidence

11
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$40K
2,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

11
BS
Battaglia SilvanaExecutive Vice President
CORCencora, Inc.
Grant or award
A$7,850
27 sh
Dec 31, 2025Jan 7, 2026
traded Dec 31, 2025
+7dSEC Form 4

Evidence

11
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$838K
52.4K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

10
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M$242K
29.3K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

10
Xu TonyDirector, CHIEF EXECUTIVE OFFICER, 10% Owner
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M$119K
16.7K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MJ
Merson JamesDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
11.1K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
CC
Canale-Theakston CarinDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
1,400 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
BD
Black DondiDirector
IDNIntellicheck, Inc.
Grant or award
A—
785 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
VC
Voinovich Michael CDirector
GBFHGBank Financial Holdings Inc.
Grant or award
A$10K
280 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
62.6K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
CT
Cabot Jeffrey TChief Accounting Officer
STEMSTEM, INC.
Grant or award
A—
3,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
AK
Ammerman Douglas KDirector
FGF&G Annuities & Life, Inc.
Grant or award
A—
762 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CC
Canale-Theakston CarinDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
2,125 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
CC
Clark George C.VP, Chief Accounting Officer
BHVNBiohaven Ltd.
Tax withholding
F$11K
1,117 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CC
Canale-Theakston CarinDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
875 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
SK
Slupkowski KrzysztofChief Credit Officer
EQBKEQUITY BANCSHARES INC
Grant or award
A—
23.2K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
GC
Griffith Curtis CDirector, Chairman and CEO
SPFISOUTH PLAINS FINANCIAL, INC.
Tax withholding
F$42K
1,108 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MM
Merchant ManishaEVP / Chief Legal Officer
BCALCalifornia BanCorp \ CA
Tax withholding
F$23K
1,238 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
SR
Spencer RyanDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
11.1K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
KM
Kelliher MikeDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
WJ
Wortendyke JasonDirector
SNSharkNinja, Inc.
Grant or award
A—
726 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
DM
David Bryant MitchellChief Wholesale Banking Office
FNBFNB CORP/PA/
Tax withholding
F$29K
1,690 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
SR
Spencer RyanDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
2,125 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
5,000 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
GC
Griffith Curtis CDirector, Chairman and CEO
SPFISOUTH PLAINS FINANCIAL, INC.
Grant or award
A—
10.6K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
GP
Gale Mary PorterDirector
RDDTReddit, Inc.
Grant or award
A—
81 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
NO
Newhouse Steven ODirector
RDDTReddit, Inc.
Grant or award
A—
87 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MS
McGinnis Eric SPresident, Climate Solutions
MODMODINE MANUFACTURING CO
Option exercise
M—
2,071 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
20.0K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
BL
Bolger LesleySee Remarks
THRYThryv Holdings, Inc.
Tax withholding
F$29K
5,047 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
1,360 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
GD
Glenn DylanDirector
IDNIntellicheck, Inc.
Grant or award
A—
2,355 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
TE
Taylor Timothy EvanDirector, VP, Finance & Operations
GSATGlobalstar, Inc.
Grant or award
A—
780 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MS
McGinnis Eric SPresident, Climate Solutions
MODMODINE MANUFACTURING CO
Option exercise
M—
9,069 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence